MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 194 filers reported holding MEDICINES CO in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $276,000 | -29.6% | 7,282 | -46.9% | 0.02% | -21.7% |
| Q2 2015 | $392,000 | +7.4% | 13,716 | +5.4% | 0.02% | +4.5% |
| Q1 2015 | $365,000 | -1.4% | 13,015 | -2.7% | 0.02% | -8.3% |
| Q4 2014 | $370,000 | +27.1% | 13,381 | +2.8% | 0.02% | +14.3% |
| Q3 2014 | $291,000 | -15.4% | 13,019 | +9.9% | 0.02% | -16.0% |
| Q2 2014 | $344,000 | +21.1% | 11,842 | +18.5% | 0.02% | +13.6% |
| Q1 2014 | $284,000 | +1.4% | 9,995 | +38.1% | 0.02% | -4.3% |
| Q4 2013 | $280,000 | +33.3% | 7,239 | +15.4% | 0.02% | +15.0% |
| Q3 2013 | $210,000 | +47.9% | 6,272 | +35.5% | 0.02% | +33.3% |
| Q2 2013 | $142,000 | -2.1% | 4,629 | +6.9% | 0.02% | -6.2% |
| Q1 2013 | $145,000 | +46.5% | 4,330 | -0.7% | 0.02% | +23.1% |
| Q2 2012 | $99,000 | -28.8% | 4,362 | -36.9% | 0.01% | -23.5% |
| Q1 2012 | $139,000 | +26.4% | 6,911 | +17.6% | 0.02% | +13.3% |
| Q4 2011 | $110,000 | +139.1% | 5,875 | +90.4% | 0.02% | +114.3% |
| Q3 2011 | $46,000 | – | 3,085 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,778,742 | $105,616,000 | 23.17% |
| Sarissa Capital Management LP | 3,636,000 | $101,626,000 | 15.30% |
| BRIDGER MANAGEMENT, LLC | 2,841,761 | $79,427,000 | 6.29% |
| HighVista Strategies LLC | 234,340 | $6,550,000 | 5.34% |
| Slate Path Capital LP | 2,170,000 | $60,652,000 | 4.91% |
| Camber Capital Management LP | 2,471,523 | $69,079,000 | 3.44% |
| Antipodean Advisors LLC | 170,000 | $4,752,000 | 3.38% |
| Parian Global Management LP | 152,400 | $4,260,000 | 2.96% |
| DLD Asset Management, LP | 2,334,800 | $65,258,000 | 2.40% |
| Boxer Capital, LLC | 600,000 | $16,770,000 | 1.94% |